To the Editor: Faced with the often disappointing outcome of therapeutic interventions in
systemic sclerosis (SSc), we read with great interest the article of Knobler et al 1 published …

Background: Effective treatment modalities for systemic sclerosis, a life-threatening and
disabling disease, are still lacking. Possible efficacy of photopheresis has been reported in …

Background Extracorporeal photochemotherapy (photopheresis), an immune‐modulating
therapy, has been demonstrated to elicit a therapeutic response in the treatment of several …

BACKGROUND: Systemic sclerosis is a multisystemic connective tissue disease with
marked involvement of the skin and joints for which few effective evidence based therapies …

Photochemotherapy in systemic sclerosis—remedy or nostrum? In this issue of theArchives,
Rook et al 1 report on the results of a randomized, investigator-blind multicenter comparison …

Background. Extracorporeal photochemotherapy, an immune‐modulating form of therapy,
has been shown to be effective in the treatment of autoimmune diseases. We evaluated the …

Background Extracorporeal photopheresis (ECP) has been considered for treatment of
patients with systemic sclerosis (SSc). Objectives To study the 12-month effects of ECP on …

We fully agree with Knobler et al1 confirming that extracorporeal photopheresis is a well-
tolerated treatment modality, which may be associated with clinical improvements in skin …

To the Editor: Since the acceptance of my manuscript for publication (J Am Acad Dermatol
1999; 41: 1020-4), DHS Clear Shampoo has changed its formulation to include benzyl …

To the Editor: Extracorporeal photochemotherapy (photopheresis) is increasingly used for
treatment of cutaneous T-cell lymphoma and some T-cell–mediated diseases such as lupus …